4
Changes in Ownership
Phathom Pharmaceuticals, Inc. Filed Acc 0001209191-23-016002
President and Chief Executive sold 1,436 shares at $8.54 ($12,265)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Curran Terrie President and Chief Executive | 2023-03-01 | Sale | −1,436 | $8.54 | $12,265 | 175,371 | D |
| Open-market sales · 1,436 sh · avg $8.54 · $12,265 | |||||||
Loading xslF345X03/doc4.xml…